Category: freely available

Lifted figure prompts retraction of Oncogene paper by Roman-Gomez

onc_cimageThe journal Oncogene has retracted a 2005 paper from a group led by Jose Roman-Gomez, a Spanish researcher who appears to be a serial image manipulator/misappropriator.

The article, “Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia,” was published online in September 2005 and has been cited 106 times, according to Thomson Scientific’s Web of Knowledge.

Now comes this: Continue reading Lifted figure prompts retraction of Oncogene paper by Roman-Gomez

“False data” forces retraction of Carbon paper co-authored by postdoc who led to PI’s suspension

carboncoverThere’s a new retraction in the journal Carbon.

The case didn’t involve a Carbon copy — say, plagiarism or duplication — but rather an instance of fraud in a Japanese university, part of a larger case we covered last August.

Here’s the retraction notice for the paper, “The role of Fe species in the pyrolysis of Fe phthalocyanine and phenolic resin for preparation of carbon-based cathode catalysts,” which appeared in August 2010: Continue reading “False data” forces retraction of Carbon paper co-authored by postdoc who led to PI’s suspension

Retraction 46 arrives for Diederik Stapel

stapel_npcDiederik Stapel has a new retraction, his 46th.

Here’s the notice for “The effects of diffuse and distinct affect. ” by Diederik A. Stapel, Willem Koomen and Kirsten I. Ruys, which appeared in the Journal of Personality and Social Psychology in 2002: Continue reading Retraction 46 arrives for Diederik Stapel

First author of recently retracted paper has another corrected, in J Ag Food Chem

jafcau_v061i004.inddA paper that shares a first author with a paper retracted in December has been corrected.

Late last year, we reported on a retraction in Antioxidants & Redox Signaling (ARDS) by Indika Edirisinghe, who was at the University of Rochester when the original paper was published, and colleagues. On January 17, the Journal of Agricultural and Food Chemistry published a correction to “Effect of Black Currant Anthocyanins on the Activation of Endothelial Nitric Oxide Synthase (eNOS) in Vitro in Human Endothelial Cells,” on which Edirisinghe is also first author.

His affiliation on that paper, originally published in July 2011, is the Illinois Institute of Technology. Here’s the correction: Continue reading First author of recently retracted paper has another corrected, in J Ag Food Chem

Study of blood pressure drug valsartan retracted

matsubaraHiroaki Matsubara, a prominent cardiologist with five Expressions of Concern and two retractions for his CV, has another retraction.

As Larry Husten, who first reported the retraction at Forbes, notes, the notice for 2009’s “Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study,” which appeared in the European Heart Journal, says very little: Continue reading Study of blood pressure drug valsartan retracted

Seizure study retracted after authors realize data got “terribly mixed”

ind j pedsA group of neonatologists in Germany has retracted a paper after apparently realizing that their data weren’t what they thought they were.

Here’s the notice, for “Low Dose Lidocaine for Refractory Seizures in Preterm Neonates,” which appeared in the Indian Journal of Pediatrics: Continue reading Seizure study retracted after authors realize data got “terribly mixed”

“Unreliable” findings fell TB gene study in PLOS ONE

plosoneHere’s a nice example of how science should work.

A team of Swiss microbiologists has retracted their 2012 paper in PLoS One on the genetics of the TB mycobacterium after learning that the fusion protein they thought they’d used in their study was in fact a different molecule.

Here’s the retraction notice for the article, “A β-lactamase based reporter system for ESX dependent protein translocation in mycobacteria,” which has been cited once, according to Thomson Scientific’s Web of Knowledge: Continue reading “Unreliable” findings fell TB gene study in PLOS ONE

C-section study retracted for being a twin

doveA group of surgeons in Cairo, Egypt have retracted their 2012 paper in the International Journal of Women’s Health for plagiarism, although that’s not quite what they’re calling it.

Here’s the notice: Continue reading C-section study retracted for being a twin

Study finds many authors aren’t sharing data when they publish — and leads to a PLOS ONE retraction

clinical chemistryA new study in Clinical Chemistry paints an alarming picture of how often scientists deposit data that they’re supposed to — but perhaps not surprisingly, papers whose authors did submit such data scored higher on a quality scale than those whose authors didn’t deposit their data.

Ken Witwer, a pathobiologist at Hopkins, was concerned that a lot of studies involving microarray-based microRNA (miRNA) weren’t complying with Minimum Information About a Microarray Experiment (MIAME) standards supposedly required by journals. So he looked at 127 such papers published between July 2011 and April 2012 in journals including PLOS ONE, the Journal of Biological Chemistry, Blood, and Clinical Chemistry, assigning each one a quality score and checking whether the authors had followed guidelines.

What he uncovered wasn’t pretty — and has already led to a retraction. From the abstract: Continue reading Study finds many authors aren’t sharing data when they publish — and leads to a PLOS ONE retraction

Shigeaki Kato notches fifth retraction

kato
Shigeaki Kato

An endocrinologist who resigned from the University of Tokyo last March as the university was investigating his work has retracted another paper.

Here’s the notice for the paper by corresponding author Shigeaki Kato and colleagues in the Journal of Bone and Mineral Research: Continue reading Shigeaki Kato notches fifth retraction